IM Cannabis (IMCC) FCF Margin Growth (1y) (2021 - 2026)
IM Cannabis (IMCC) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -209.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 301.00 |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -3,779.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,779.00 |
| Dec 31, 2025 | 6,041.00 |
| Sep 30, 2025 | -4,560.00 |
| Jun 30, 2025 | -1,083.00 |
| Mar 31, 2025 | 4,090.00 |
| Dec 31, 2024 | -2,097.00 |
| Sep 30, 2024 | -2,292.00 |
| Jun 30, 2024 | 6,017.00 |
| Mar 31, 2024 | 3,990.00 |
| Dec 31, 2023 | 355.00 |
| Sep 30, 2023 | 3,541.00 |
| Jun 30, 2023 | -4,447.00 |
| Mar 31, 2023 | 3,781.00 |
| Dec 31, 2022 | -5,020.00 |
| Sep 30, 2022 | 27,091.00 |
| Jun 30, 2022 | 12,008.00 |
| Mar 31, 2022 | -448.00 |
| Dec 31, 2021 | 2,785.00 |
| Sep 30, 2021 | -23,557.00 |
| Jun 30, 2021 | -5,338.00 |